Longevity Vision Fund

Longevity Vision Fund operates as a venture capital entity primarily focused on financing advancements within the longevity sphere, encompassing life sciences and healthcare technologies. The firm actively invests in breakthroughs poised to extend healthy human lifespan, emphasizing innovative solutions that make longevity more attainable for a broader population. Its strategic approach targets early to growth-stage companies developing foundational technologies in areas like therapeutics, diagnostics, and preventative care.

The fund was established by Sergey Young, driven by his personal mission to positively impact the lifespan and health of a billion people. His foundational insight centered on the conviction that achieving widespread longevity necessitates making relevant technologies and treatments affordable and broadly accessible. This perspective informed the creation of the fund as a mechanism to accelerate the development and deployment of such critical innovations.

Longevity Vision Fund backs companies creating products and services that align with its core tenet of extending healthy human life. Its ultimate vision is to foster an ecosystem where longevity is not a luxury but a fundamental and achievable state for humanity. The fund therefore seeks to catalyze transformative shifts in healthcare, ensuring a future where living a healthy 100 years becomes a global reality.